The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis

被引:864
作者
Swerdlow, Daniel I. [1 ]
Holmes, Michael V. [1 ]
Kuchenbaecker, Karoline B. [1 ]
Engmann, Jorgen E. L. [1 ]
Shah, Tina [1 ]
Sofat, Reecha [1 ]
Guo, Yiran [1 ]
Chung, Christina [1 ]
Peasey, Anne [1 ]
Ster, Roman Pfi [1 ]
Mooijaart, Simon P. [1 ]
Ireland, Helen A. [1 ]
Leusink, Maarten [1 ]
Langenberg, Claudia [1 ]
Li, KaWah [1 ]
Palmen, Jutta [1 ]
Howard, Philip [1 ]
Cooper, Jackie A. [1 ]
Drenos, Fotios [1 ]
Hardy, John [1 ]
Nalls, Michael A. [1 ]
Li, Yun Rose [1 ]
Lowe, Gordon [1 ]
Stewart, Marlene [1 ]
Bielinski, Suzette J. [1 ]
Peto, Julian [1 ]
Timpson, Nicholas J. [1 ]
Gallacher, John [1 ]
Dunlop, Malcolm [1 ]
Houlston, Richard [1 ]
Tomlinson, Ian [1 ]
Tzoulaki, Ioanna [1 ]
Luan, Jian'an [1 ]
Boer, Jolanda M. A. [1 ]
Forouhi, Nita G. [1 ]
Onland-Moret, N. Charlotte [1 ]
van der Schouw, Yvonne T. [1 ]
Schnabel, Renate B. [1 ]
Hubacek, Jaroslav A. [1 ]
Kubinova, Ruzena [1 ]
Baceviciene, Migle [1 ]
Tamosiunas, Abdonas [1 ]
Pajak, Andrzej [1 ]
Topor-Madry, Roman [1 ]
Malyutina, Sofi A. [1 ]
Baldassarre, Damiano [1 ]
Sennblad, Bengt [1 ]
Tremoli, Elena [1 ]
de Faire, Ulf [1 ]
Ferrucci, Luigi [1 ]
机构
[1] UCL, UCL Inst Epidemiol & Hlth Care, Res Dept Epidemiol & Publ Hlth, Genet Epidemiol Grp, London WC1E 6BT, England
关键词
GENOME-WIDE ASSOCIATION; C-REACTIVE PROTEIN; INDIVIDUAL PARTICIPANTS DATA; RHEUMATOID-ARTHRITIS; IL-6; RECEPTOR; DOUBLE-BLIND; JOINT ANALYSIS; SOLUBLE IL-6; TOCILIZUMAB; MECHANISMS;
D O I
10.1016/S0140-6736(12)60110-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background A high circulating concentration of interleukin 6 is associated with increased risk of coronary heart disease. Blockade of the interleukin-6 receptor (IL6R) with a monoclonal antibody (tocilizumab) licensed for treatment of rheumatoid arthritis reduces systemic and articular inflammation. However, whether IL6R blockade also reduces risk of coronary heart disease is unknown. Methods Applying the mendelian randomisation principle, we used single nucleotide polymorphisms (SNPs) in the gene IL6R to evaluate the likely efficacy and safety of IL6R inhibition for primary prevention of coronary heart disease. We compared genetic findings with the effects of tocilizumab reported in randomised trials in patients with rheumatoid arthritis. Findings In 40 studies including up to 133 449 individuals, an IL6R SNP (rs7529229) marking a non-synonymous IL6R variant (rs8192284; p.Asp358Ala) was associated with increased circulating log interleukin-6 concentration (increase per allele 9.45%, 95% CI 8.34-10.57) as well as reduced C-reactive protein (decrease per allele 8.35%, 95% CI 7.31-9.38) and fibrinogen concentrations (decrease per allele 0.85%, 95% CI 0.60-1.10). This pattern of effects was consistent with IL6R blockade from infusions of tocilizumab (4-8 mg/kg every 4 weeks) in patients with rheumatoid arthritis studied in randomised trials. In 25 458 coronary heart disease cases and 100 740 controls, the IL6R rs7529229 SNP was associated with a decreased odds of coronary heart disease events (per allele odds ratio 0.95, 95% CI 0.93-0.97, p=1.53x10(-5)). Interpretation On the basis of genetic evidence in human beings, IL6R signalling seems to have a causal role in development of coronary heart disease. IL6R blockade could provide a novel therapeutic approach to prevention of coronary heart disease that warrants testing in suitably powered randomised trials. Genetic studies in populations could be used more widely to help to validate and prioritise novel drug targets or to repurpose existing agents and targets for new therapeutic uses.
引用
收藏
页码:1214 / 1224
页数:11
相关论文
共 49 条
[1]  
[Anonymous], BRIEF DOC ARTHR ADV
[2]  
[Anonymous], COCHRANE DATABASE SY
[3]  
[Anonymous], EUR PUBL ASS REP ROA
[4]  
[Anonymous], TOC TREATM RHEUM ART
[5]   Insight into the nature of the CRP-coronary event association using Mendelian randomization [J].
Casas, Juan P. ;
Shah, Tina ;
Cooper, Jackie ;
Hawe, Emma ;
McMahon, Alex D. ;
Gaffney, Dairena ;
Packard, Christopher J. ;
O'Reilly, Denis S. ;
Juhan-Vague, Irene ;
Yudkin, John S. ;
Tremoli, Elena ;
Margaglione, Maurizio ;
Di Minno, Giovanni ;
Hamsten, Anders ;
Kooistra, Teake ;
Stephens, Jeffrey W. ;
Hurel, Steven J. ;
Livingstone, Shona ;
Colhoun, Helen M. ;
Miller, George J. ;
Bautista, Leonelo E. ;
Meade, Tom ;
Sattar, Naveed ;
Humphries, Steve E. ;
Hingorani, Aroon D. .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2006, 35 (04) :922-931
[6]   ADAM17-mediated shedding of the IL6R induces cleavage of the membrane stub by γ-secretase [J].
Chalaris, Athena ;
Gewiese, Jessica ;
Paliga, Krzysztof ;
Fleig, Lina ;
Schneede, Alex ;
Krieger, Karsten ;
Rose-John, Stefan ;
Scheller, Juergen .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2010, 1803 (02) :234-245
[7]   Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions [J].
Choy, E. ;
Sattar, N. .
ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (04) :460-469
[8]   Long-term interleukin-6 levels and subsequent risk of coronary heart disease: Two new prospective studies and a systematic review [J].
Danesh, John ;
Kaptoge, Stephen ;
Mann, Andrea G. ;
Sarwar, Nadeem ;
Wood, Angela ;
Angleman, Sara B. ;
Wensley, Frances ;
Higgins, Julian P. T. ;
Lennon, Lucy ;
Eiriksdottir, Gudny ;
Rumley, Ann ;
Whincup, Peter H. ;
Lowe, Gordon D. O. ;
Gudnason, Vilmundur .
PLOS MEDICINE, 2008, 5 (04) :600-610
[9]   Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease [J].
Davila, Sonia ;
Wright, Victoria J. ;
Khor, Chiea Chuen ;
Sim, Kar Seng ;
Binder, Alexander ;
Breunis, Willemijn B. ;
Inwald, David ;
Nadel, Simon ;
Betts, Helen ;
Carrol, Enitan D. ;
de Groot, Ronald ;
Hermans, Peter W. M. ;
Hazelzet, Jan ;
Emonts, Marieke ;
Lim, Chui Chin ;
Kuijpers, Taco W. ;
Martinon-Torres, Federico ;
Salas, Antonio ;
Zenz, Werner ;
Levin, Michael ;
Hibberd, Martin L. .
NATURE GENETICS, 2010, 42 (09) :772-U63
[10]   Genetic Loci Associated With C-Reactive Protein Levels and Risk of Coronary Heart Disease [J].
Elliott, Paul ;
Chambers, John C. ;
Zhang, Weihua ;
Clarke, Robert ;
Hopewell, Jemma C. ;
Peden, John F. ;
Erdmann, Jeanette ;
Braund, Peter ;
Engert, James C. ;
Bennett, Derrick ;
Coin, Lachlan ;
Ashby, Deborah ;
Tzoulaki, Ioanna ;
Brown, Ian J. ;
Mt-Isa, Shahrul ;
McCarthy, Mark I. ;
Peltonen, Leena ;
Freimer, Nelson B. ;
Farrall, Martin ;
Ruokonen, Aimo ;
Hamsten, Anders ;
Lim, Noha ;
Froguel, Philippe ;
Waterworth, Dawn M. ;
Vollenweider, Peter ;
Waeber, Gerard ;
Jarvelin, Marjo-Riitta ;
Mooser, Vincent ;
Scott, James ;
Hall, Alistair S. ;
Schunkert, Heribert ;
Anand, Sonia S. ;
Collins, Rory ;
Samani, Nilesh J. ;
Watkins, Hugh ;
Kooner, Jaspal S. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (01) :37-48